Miguel Paja1, Carles Zafón2, Carmela Iglesias3, Aitziber Ugalde4, Jose Manuel Cameselle-Teijeiro5, Gemma Rodríguez-Carnero6, Pilar Fernández-Seara7, Emma Anda8, Antónia Povoa9, Hernán Quiceno10, Nancy M Sánchez-Gómez11, Clarisa González12, Luis García-Pascual13, Inés Gómez de la Riva14, Concha Blanco15, Telma Meizoso16, Garcilaso Riesco-Eizaguirre17, Ismael Capel18, María Victoria Ortega19, Isabel Mancha20, Montserrat Chao21, Victoria Alcázar22, Esther Roselló23, Javier Maravall24, Susana López-Agulló25, Antonia Pérez-Lázaro26, Pascual Meseguer27, Javier Sanz28, Jose J Paricio29, Saioa Echeverría30, Ángel Castaño31, Rosa M Bella32. 1. Department of Endocrinology, Hospital Universitario Basurto, Bilbao, Spain. miguel.pajafano@osakidetza.eus. 2. Department of Endocrinology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. 3. Department of Pathology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. 4. Department of Pathology, Hospital Universitario Basurto, Bilbao, Spain. 5. Department of Pathology, Complejo Hospitalario Universitario Santiago de Compostela, La Coruña, Spain. 6. Department of Endocrinology, Complejo Hospitalario Universitario Santiago de Compostela, La Coruña, Spain. 7. Department of Pathology, Complejo Hospitalario de Navarra, Pamplona, Spain. 8. Department of Endocrinology, Complejo Hospitalario de Navarra, Pamplona, Spain. 9. Department of Surgery, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal. 10. Department of Pathology, Fundación Jiménez Díaz, Madrid, Spain. 11. Department of Endocrinology, Fundación Jiménez Díaz, Madrid, Spain. 12. Department of Pathology, Hospital Universitario Mútua de Terrassa, Terrassa, Spain. 13. Department of Endocrinology, Hospital Universitario Mútua de Terrassa, Terrassa, Spain. 14. Department of Pathology, Hospital Universitario Príncipe de Asturias, Madrid, Spain. 15. Department of Endocrinology, Hospital Universitario Príncipe de Asturias, Madrid, Spain. 16. Department of Pathology, Hospital General de Móstoles, Madrid, Spain. 17. Department of Endocrinology, Hospital General de Móstoles, Madrid, Spain. 18. Department of Endocrinology, Corporació Parc Taulí, Sabadell, Spain. 19. Department of Pathology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. 20. Department of Endocrinology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. 21. Department of Pathology, Hospital Universitario Severo Ochoa, Leganés, Spain. 22. Department of Endocrinology, Hospital Universitario Severo Ochoa, Leganés, Spain. 23. Department of Pathology, Hospital General Universitario de Castellón, Castellón, Spain. 24. Department of Endocrinology, Hospital General Universitario de Castellón, Castellón, Spain. 25. Department of Pathology, Hospital Universitario La Fe, Valencia, Spain. 26. Department of Endocrinology, Hospital Universitario La Fe, Valencia, Spain. 27. Department of Pathology, Hospital Lluís Alcanyís, Xàtiva, Spain. 28. Department of Endocrinology, Hospital Lluís Alcanyís, Xàtiva, Spain. 29. Department of Pathology, Clínica Universitaria de Navarra, Pamplona, Spain. 30. Department of Endocrinology, Clínica Universitaria de Navarra, Pamplona, Spain. 31. Department of Pathology, Hospital Universitario de Fuenlabrada, Madrid, Spain. 32. Department of Pathology, Corporació Parc Taulí, Sabadell, Spain.
Abstract
PURPOSE: To determine the rate of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in a multi-institutional series from the Iberian Peninsula and describing this NIFTP cohort. METHODS: Retrospective study of papillary thyroid carcinoma (PTC) or well-differentiated tumours of uncertain malignant potential (WDT-UMP) diagnosed between 2005 and 2015 and measuring ≥5 mm in adult patients from 17 hospitals. Pathological reports were reviewed to determine the cases that fulfil the original criteria of NIFTP and histology was reassessed. Rates were correlated with the number of PTC and its follicular variant (FVPTC) of each institution. Demographic data, histology, management, and follow-up of the reclassified NIFTP cohort were recorded. RESULTS: A total of 182 cases with NIFTP criteria were identified: 174/3372 PTC (rate: 5.2%; range: 0-12.1%) and 8/19 WDT-UMP (42.1%). NIFTP rate showed linear correlation with total PTC (p: 0.03) and FVPTC (p: 0.007) identified at each centre. Ultrasound findings were non-suspicious in 60.1%. Fine-needle cytology or core biopsy diagnoses were undetermined in 49.7%. Most patients were treated with total thyroidectomy. No case had nodal disease. Among patients with total thyroidectomy, 89.7% had an excellent response evaluated 1 year after surgery. There were no structural persistence or relapses. Five patients showed residual thyroglobulin after 90 months of mean follow-up. CONCLUSIONS: NIFTP rate is low but highly variable in neighbouring institutions of the Iberian Peninsula. This study suggests pathologist's interpretation of nuclear alterations as the main cause of these differences. Patients disclosed an excellent outcome, even without using the strictest criteria.
PURPOSE: To determine the rate of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in a multi-institutional series from the Iberian Peninsula and describing this NIFTP cohort. METHODS: Retrospective study of papillary thyroid carcinoma (PTC) or well-differentiated tumours of uncertain malignant potential (WDT-UMP) diagnosed between 2005 and 2015 and measuring ≥5 mm in adult patients from 17 hospitals. Pathological reports were reviewed to determine the cases that fulfil the original criteria of NIFTP and histology was reassessed. Rates were correlated with the number of PTC and its follicular variant (FVPTC) of each institution. Demographic data, histology, management, and follow-up of the reclassified NIFTP cohort were recorded. RESULTS: A total of 182 cases with NIFTP criteria were identified: 174/3372 PTC (rate: 5.2%; range: 0-12.1%) and 8/19 WDT-UMP (42.1%). NIFTP rate showed linear correlation with total PTC (p: 0.03) and FVPTC (p: 0.007) identified at each centre. Ultrasound findings were non-suspicious in 60.1%. Fine-needle cytology or core biopsy diagnoses were undetermined in 49.7%. Most patients were treated with total thyroidectomy. No case had nodal disease. Among patients with total thyroidectomy, 89.7% had an excellent response evaluated 1 year after surgery. There were no structural persistence or relapses. Five patients showed residual thyroglobulin after 90 months of mean follow-up. CONCLUSIONS:NIFTP rate is low but highly variable in neighbouring institutions of the Iberian Peninsula. This study suggests pathologist's interpretation of nuclear alterations as the main cause of these differences. Patients disclosed an excellent outcome, even without using the strictest criteria.
Authors: Yuri E Nikiforov; Raja R Seethala; Giovanni Tallini; Zubair W Baloch; Fulvio Basolo; Lester D R Thompson; Justine A Barletta; Bruce M Wenig; Abir Al Ghuzlan; Kennichi Kakudo; Thomas J Giordano; Venancio A Alves; Elham Khanafshar; Sylvia L Asa; Adel K El-Naggar; William E Gooding; Steven P Hodak; Ricardo V Lloyd; Guy Maytal; Ozgur Mete; Marina N Nikiforova; Vania Nosé; Mauro Papotti; David N Poller; Peter M Sadow; Arthur S Tischler; R Michael Tuttle; Kathryn B Wall; Virginia A LiVolsi; Gregory W Randolph; Ronald A Ghossein Journal: JAMA Oncol Date: 2016-08-01 Impact factor: 31.777
Authors: Raman Mehrzad; Michiya Nishino; James Connolly; Helen Wang; Peter Mowschenson; Per-Olof Hasselgren Journal: Surgery Date: 2016-01-11 Impact factor: 3.982
Authors: Bryan R Haugen; Anna M Sawka; Erik K Alexander; Keith C Bible; Patrizio Caturegli; Gerard M Doherty; Susan J Mandel; John C Morris; Aziza Nassar; Furio Pacini; Martin Schlumberger; Kathryn Schuff; Steven I Sherman; Hilary Somerset; Julie Ann Sosa; David L Steward; Leonard Wartofsky; Michelle D Williams Journal: Thyroid Date: 2017-02-21 Impact factor: 6.568
Authors: Melina Sabán; Norma Tolaba; Ana María Orlandi; Susana Deutsch; Fabián Pitoia; Alicia Lowenstein; María Cristina Calabrese; Andrea Cavallo; Alejandro Iotti; Marcelo Monteros Alvi; Marcelo Nallar; Ana Jaén; Silvina Figurelli; Fernando Carrizo; Antonio Colobraro; Gabriela García Tascón; María Saccoliti; Andrea Paes de Lima; Melisa Lencioni; Inés Califano; Carmen Cabezón Journal: Endocrine Date: 2022-07-07 Impact factor: 3.925